A Genentech-partnered Vijay Pande favorite nabs $52M to advance an AI pipeline

Evan Feinberg could have picked a better time to launch his AI biotech, Genesis. He announced a $4.1 million round last November; by March, South San Francisco, California was under lockdown.

Still, a year later, he can look back at his early tenure with a certain degree of satisfaction.